WAM
ANVS icon

Warberg Asset Management’s Annovis Bio ANVS Stock Holding History

Warberg Asset Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39,000
Closed -$58.5K – 187
2025
Q1 		$58.5K Buy
+39,000
New +$119K 0.01% 129

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Warberg Asset Management's ANVS Position: Q2 2025 in Review

Warberg Asset Management sold out of Annovis Bio (ANVS) in Q2 2025, closing a stake of 39,000 shares — an estimated $58.5K sold.

Warberg Asset Management first reported a position in ANVS in Q1 2025 and held it in 1 quarter. The position peaked at $58.5K in Q1 2025. 42 funds tracked by Wall St. Rank hold ANVS as of Q2 2025.

  • Warberg Asset Management reported no remaining Annovis Bio position as of Q2 2025 after selling out during the quarter.
  • Warberg Asset Management sold 39,000 Annovis Bio shares in Q2 2025, an estimated $58.5K.
  • Warberg Asset Management first reported a position in Annovis Bio in Q1 2025 and held it in 1 quarter.
  • Warberg Asset Management's Annovis Bio position peaked at $58.5K in Q1 2025.
  • 42 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2025.

Based on Warberg Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.